Texas ABO Incompatibility Birth Injury Lawyer

Protecting Texas Families After Preventable Blood Incompatibility Injuries

Understanding ABO and Rh Incompatibility Claims

ABO and Rh incompatibility claims arise when medical providers fail to identify or treat a mismatch between maternal and fetal blood types, leading to the destruction of the baby’s red blood cells, a condition known as hemolytic disease. These blood-related conditions can lead to serious complications if the medical team does not intervene.

The biological mismatch itself is not malpractice. The potential negligence lies in the failure to detect it, monitor it, or treat it in time.

Here is how the two types differ. Rh incompatibility, a condition where a mother who is Rh-negative carries a baby who is Rh-positive, involves the Rh factor protein found on red blood cells. During pregnancy or delivery, the mother’s immune system can produce antibodies that attack the baby’s red blood cells. ABO incompatibility, a mismatch in the A, B, or O blood type groups, follows a similar mechanism but is generally milder in its first presentation.

Both conditions can trigger the same dangerous chain of events. The mother’s antibodies cross the placenta and begin destroying fetal red blood cells. According to the National Center for Biotechnology Information (NCBI), this process, called hemolytic disease of the fetus and newborn, can lead to severe anemia and organ damage if left unmanaged. This biological conflict can be dangerous because the foreign antibodies aggressively target the fetus, turning a natural biological difference into a medical emergency if not properly monitored.

Feature	Rh Incompatibility	ABO Incompatibility
Cause	Rh-negative mother / Rh-positive baby	Mother is type O / Baby is type A or B
Antibody trigger	Prior pregnancy or blood exposure	Can occur in a first pregnancy
Typical severity	Can be severe, worsens with each pregnancy	Usually milder, but can escalate
Prevention	RhoGAM injection	No equivalent vaccine; monitoring is key

The critical question in any legal claim is whether the care team followed established protocols to catch and respond to these mismatches before they caused harm.

The Standard of Care: Screening and Prevention Failures

The standard of care, the accepted level of treatment a reasonably competent provider would deliver under similar circumstances, requires obstetricians to perform prenatal blood typing and antibody screening early in pregnancy. The standard of care establishes the legal baseline for how doctors should screen for these risks.

A Texas ABO incompatibility lawyer will typically investigate whether the following steps were taken:

• Blood type and Rh factor testing at the first prenatal visit
• Indirect Coombs test, an antibody screen that detects whether the mother’s blood has developed antibodies against the baby’s red blood cells
• Rh immune globulin (RhIg) administration, a prophylactic treatment also known as the RhoGAM shot, at approximately 28 weeks of gestation and again within 72 hours after delivery for Rh-negative mothers
• Repeat antibody screening later in pregnancy to monitor for new sensitization
• Ongoing fetal surveillance if antibodies are detected, including ultrasound monitoring for signs of fetal anemia

Missing any of these routine steps can constitute negligence. The Indirect Coombs test, for example, is a standard lab draw. If a provider skips it or fails to act on abnormal results, the window to prevent serious injury may close.

Proper prenatal blood typing and antibody screening relies on these checkpoints to manage risk. Without the RhoGAM shot, an Rh-negative mother is likely to become sensitized. Once sensitization occurs, RhIg is no longer effective, and the pregnancy becomes high-risk, leaving the baby vulnerable to antibody attacks that could have been completely avoided.

Medical Consequences of Untreated Incompatibility

Untreated blood mismatches can trigger a spectrum of medical consequences for the baby. When a blood mismatch goes undetected or untreated, the condition can progress from manageable to severe.

Hemolytic disease of the fetus and newborn (HDFN), the clinical term for the immune-driven destruction of a baby’s red blood cells, exists on a spectrum. In mild cases, the baby may show signs of anemia at birth. In more serious cases, the condition can advance to erythroblastosis fetalis, where the baby’s body struggles to replace destroyed red blood cells fast enough.

The most dangerous progression is hydrops fetalis, a life-threatening condition marked by severe fluid buildup in the baby’s tissues and organs. At that stage, the risk of permanent injury or death rises significantly. Each of these escalations represents a point where earlier intervention could have changed the outcome, and that is exactly what our medical and legal teams evaluate.

Recognizing Severe Injuries: Jaundice and Kernicterus

If a blood mismatch is left untreated, it can cause severe hyperbilirubinemia, a dangerously high level of bilirubin in the blood, which may escalate to kernicterus, a form of permanent brain damage caused by bilirubin accumulating in the brain. Jaundice and kernicterus are specific neurological and physical risks associated with untreated blood incompatibility.

Many newborns develop mild jaundice in their first few days of life. That is common and typically harmless. But jaundice caused by hemolysis, the active destruction of red blood cells, is different. It can spike rapidly and requires prompt treatment.

The destruction of red blood cells also causes fetal anemia, a condition where oxygen delivery is compromised. If this anemia or the resulting jaundice is ignored, the baby’s health can deteriorate quickly.

The progression often looks like this:

• Mild jaundice with yellowing of the skin and eyes shortly after birth
• Worsening lethargy, poor feeding, and high-pitched crying as bilirubin levels rise
• Kernicterus, which can cause cerebral palsy, hearing loss, and lifelong developmental delays

The American Academy of Pediatrics’ clinical practice guideline on hyperbilirubinemia management outlines clear thresholds for when phototherapy (light therapy) or exchange transfusion should be initiated. When providers fail to order timely treatment or discharge a jaundiced newborn without proper follow-up, the consequences can lead to permanent brain damage.

Contact the Texas Birth Injury Attorneys at Hastings Law Firm Today for Help

No family should carry the financial and emotional weight of an injury that proper screening could have prevented. Seeking legal advice is a step toward understanding your rights after a medical error.

If your child was harmed by an undetected or untreated blood incompatibility, Hastings Law Firm is here to help you find answers. Our team of attorneys, nurse consultants, and medical experts will review your records, identify where the standard of care may have been breached, and explain your legal options.

As a Texas ABO incompatibility birth injury lawyer, we handle every step of the process, and you pay no fees unless we recover compensation for your family. Contact us today for a free, confidential case evaluation.